HCW Biologics Inc
Price
FilingsNewest: S-1, Registration of sharesOct 2 →Insiders3 insiders bought $431,530 in 3 open-market buys. No sales.→HoldersJane Street 3.2%Citadel 1.2%Vanguard Fiduciary Trust 0.4%→Financing →PeersClosest companies: FATE, CABA, TCRX→
From the filings
Figures
- Revenue
- $6.7Mlast 12 months
- Net income
- −$5.6Mlast 12 months
- Operating cash flow
- −$11.5Mlast 12 months
- Cash and equivalents
- $741,324at the last balance sheet
- Total debt
- $6.6Mat the last balance sheet
- Shares outstanding
- 1.6M shareson issue